In the present study, we determined the feasibility of three genes (ERO1A, OSBPL3 and IFI44L) working as potential biomarkers in pancreatic ductal adenocarcinoma (PDAC). Here, IFI44L is linked to pancreatic ductal adenocarcinoma.